Chief, Division of Infectious Diseases
Director of Hospital Epidemiology and Infection Control
To see if Stuart H. Cohen is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).
I chose my specialty because I had an interest in microbiology. Most of the new and challenging syndromes are connected with infectious diseases. Humor and compassion are the methods I use in my practice. I try to personalize patient care to the needs of each patient. In my view, appropriate immunizations and the patient's educational knowledge about his or her condition are most important for good health. In addition, at UC Davis, we have a vital facility that generates new knowledge and the specialists necessary to handle the most complex cases.
Stuart H. Cohen specializes in clinical infectious diseases and infection control in the hospital environment. He is interested in AIDS, HIV infection and treatment of immunocompromised patients and serves as primary infectious diseases consultant to transplant programs. Cohen uses molecular biology to investigate epidemiology of resistant microorganisms. His laboratory-based studies look at susceptibility testing of HIV clinical isolates to multiple antiretroviral agents. Additional research focuses on new antimicrobial agents and chemokine and cytokine level changes.
B.S., University of Illinois, Urbana-Champaign IL 1974
M.D., Chicago Medical School, Chicago IL 1978
Internal Medicine, University of New Mexico, Albuquerque NM 1978-1981
Infectious Diseases, UC Davis Medical Center, Sacramento CA 1981-1983
Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the Treatment of Covid-19 - Preliminary Report. N Engl J Med. 2020;10.1056/NEJMoa200776. [published online ahead of print, 2020 May 22]
Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, Castagna A, Feldt T, Green G, Green ML, Lescure FX, Nicastri E, Oda R, Yo K, Quiros-Roldan E, Studemeister A, Redinski J, Ahmed S, Bernett J, Chelliah D, Chen D, Chihara S, Cohen SH, et al. Compassionate Use of Remdesivir for Patients with Severe Covid-19. N Engl J Med. 2020;382(24):2327-2336
Mitra A, Dwyre DM, Schivo M, Thompson GR III, Cohen SH, Ku N, Graff JP. Leukoerythroblastic reaction in a patient with COVID-19 infection. Am J Hematol. 2020;10.1002/ajh.25793. [published online ahead of print, 2020 Mar 25]
Sanville B, Corbett R, Pidcock W, Hardin K, Sebat C, Nguyen MV, Thompson GR III, Haczku A, Schivo M, Cohen SH. A Community Transmitted Case of Severe Acute Respiratory Distress Syndrome due to SARS CoV2 in the United States. Clin Infect Dis. 2020;ciaa347. [published online ahead of print, 2020 Mar 30]
Wilson MR, Sample HA, Zorn KC, et al. Clinical Metagenomic Sequencing for Diagnosis of Meningitis and Encephalitis. N Engl J Med. 2019;380(24):2327‐2340.
Heidari A, Quinlan M, Benjamin DJ, et al. Isavuconazole in the Treatment of Coccidioidal Meningitis. Antimicrob Agents Chemother. 2019 Feb 26;63(3):e02232-18.
Stewart ER, Eldridge ML, McHardy I, Cohen SH, Thompson GR III. Liposomal Amphotericin B as Monotherapy in Relapsed Coccidioidal Meningitis. 183(3):619-622.
Bui C, Zhu E, Donnelley MA, Wilson MD, Morita M, Cohen SH, Brown J. Antimicrobial stewardship programs that target only high- cost, broad-spectrum antimicrobials miss opportunities to reduce Clostridium difficile infections. American Journal of Infection Control. 2016;44:1684-1686.
Polage CR, Turkiewicz JV, Cohen SH. The never-ending struggle with laboratory testing for Clostridium difficile infection. Journal Of Comparative Effectiveness Research. 2016;5(2):113-116.
Gupta MP, Coombs P, Prockop SE, Hasan AA, Doubrovina E, O'Reilly RJ, Cohen SH, Park SS, Kiss S. Treatment of cytomegalovirus retinitis with cytomegalovirus-specific T-lymphocyte infusion. Ophthalmic Surg Lasers Imaging Retina. 2015;46:80-2.